BioCentury | Oct 30, 2020
Distillery Therapeutics

KSP as a neuroblastoma target

...Hansson, K. et al. Sci. Transl. Med.; published online Sept. 23, 2020doi:10.1126/scitranslmed.aba4434CONTACT: Daniel Bexell, Lund University, Lund, Swedenemail: daniel.bexell@med.lu.se Claire Quang Lund University Kinesin...
BioCentury | Aug 1, 2020
Tools & Techniques

A plasma tau marker gains support for diagnosing Alzheimer’s disease

...bode well for development of plasma tau tests. One study, published in JAMA by a Lund University-led...
BioCentury | Jun 4, 2020
Emerging Company Profile

Hayden’s fifth venture, neuro-focused Prilenia, raises $62.5M in Forbion-led A round

...September 2018 by Michael Hayden and Talisman Capital University collaborators: Independent researchers at Grenoble-Alpes Universite, Lund University...
BioCentury | Jan 31, 2020
Distillery Therapeutics

Hydrogel-delivered, thrombin-derived peptide to treat and prevent Staphylococcus and Pseudomonas infections

...published online Jan. 1, 2020 doi:10.1126/scitranslmed.aax6601 CONTACT: Manoj Puthia, Lund University, Lund, Sweden email: manoj.puthia@med.lu.se Claire Quang Lund University Lipopolysaccharide...
BioCentury | Apr 22, 2019
Distillery Therapeutics

Targeting NETs with DNASE1 in pneumococcal meningitis

...Tirthankar Mohanty, Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden email: tirthankar.mohanty@med.lu.se Sandi Wong Lund University Deoxyribonuclease...
BioCentury | Jan 25, 2019
Financial News

Wren raises £18M series A for protein misfolding pipeline

...its pipeline of protein misfolding disease candidates. Spun out from the University of Cambridge and Lund University...
BioCentury | Jan 22, 2019
Financial News

Wren raises £18M series A for protein misfolding pipeline

...its pipeline of protein misfolding disease candidates. Spun out from the University of Cambridge and Lund University...
BioCentury | Nov 8, 2018
Emerging Company Profile

Abarceo: restoring beta cell function

...dosing, and none of which targets the underlying disease mechanism. Abarceo, which spun out of Lund University...
...Clinical status: Preclinical Founded: 2017 by Claes Wollheim, Albert Salehi and Tara Heitner University collaborators: Lund University...
...CEO: Tara Heitner Patents: None issued Companies and Institutions Mentioned Abarceo Pharma AB, Malmö, Sweden Lund University...
BioCentury | Sep 21, 2018
Company News

Novo's R&D restructuring adds to innovation push

...prevent the common problem of insulin therapy-induced hypoglycemia (see "Sweet Switch" ). Academic partnerships with Lund University...
BioCentury | Sep 18, 2018
Company News

Novo's R&D restructuring adds to innovation push

...prevent the common problem of insulin therapy-induced hypoglycemia (see "Sweet Switch" ). Academic partnerships with Lund University...
Items per page:
1 - 10 of 95
BioCentury | Oct 30, 2020
Distillery Therapeutics

KSP as a neuroblastoma target

...Hansson, K. et al. Sci. Transl. Med.; published online Sept. 23, 2020doi:10.1126/scitranslmed.aba4434CONTACT: Daniel Bexell, Lund University, Lund, Swedenemail: daniel.bexell@med.lu.se Claire Quang Lund University Kinesin...
BioCentury | Aug 1, 2020
Tools & Techniques

A plasma tau marker gains support for diagnosing Alzheimer’s disease

...bode well for development of plasma tau tests. One study, published in JAMA by a Lund University-led...
BioCentury | Jun 4, 2020
Emerging Company Profile

Hayden’s fifth venture, neuro-focused Prilenia, raises $62.5M in Forbion-led A round

...September 2018 by Michael Hayden and Talisman Capital University collaborators: Independent researchers at Grenoble-Alpes Universite, Lund University...
BioCentury | Jan 31, 2020
Distillery Therapeutics

Hydrogel-delivered, thrombin-derived peptide to treat and prevent Staphylococcus and Pseudomonas infections

...published online Jan. 1, 2020 doi:10.1126/scitranslmed.aax6601 CONTACT: Manoj Puthia, Lund University, Lund, Sweden email: manoj.puthia@med.lu.se Claire Quang Lund University Lipopolysaccharide...
BioCentury | Apr 22, 2019
Distillery Therapeutics

Targeting NETs with DNASE1 in pneumococcal meningitis

...Tirthankar Mohanty, Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden email: tirthankar.mohanty@med.lu.se Sandi Wong Lund University Deoxyribonuclease...
BioCentury | Jan 25, 2019
Financial News

Wren raises £18M series A for protein misfolding pipeline

...its pipeline of protein misfolding disease candidates. Spun out from the University of Cambridge and Lund University...
BioCentury | Jan 22, 2019
Financial News

Wren raises £18M series A for protein misfolding pipeline

...its pipeline of protein misfolding disease candidates. Spun out from the University of Cambridge and Lund University...
BioCentury | Nov 8, 2018
Emerging Company Profile

Abarceo: restoring beta cell function

...dosing, and none of which targets the underlying disease mechanism. Abarceo, which spun out of Lund University...
...Clinical status: Preclinical Founded: 2017 by Claes Wollheim, Albert Salehi and Tara Heitner University collaborators: Lund University...
...CEO: Tara Heitner Patents: None issued Companies and Institutions Mentioned Abarceo Pharma AB, Malmö, Sweden Lund University...
BioCentury | Sep 21, 2018
Company News

Novo's R&D restructuring adds to innovation push

...prevent the common problem of insulin therapy-induced hypoglycemia (see "Sweet Switch" ). Academic partnerships with Lund University...
BioCentury | Sep 18, 2018
Company News

Novo's R&D restructuring adds to innovation push

...prevent the common problem of insulin therapy-induced hypoglycemia (see "Sweet Switch" ). Academic partnerships with Lund University...
Items per page:
1 - 10 of 95